Ayala Pharmaceuticals Inc (ADXS)

[itk331]

Just posted this in Stock Twits (https://stocktwits.com/symbol/Adxs) -
Opening up a can of worms guys (sorry but this needs to be talked openly before people hit the 'panic' button..). why should the Advaxis share holder today hold (not sell) a STILL clinical stage trial / baby-bio like Advaxis who has failed its stockholders OVER and OVER! especially since 2015 summer, when we pretty much know our money will potentially DOUBLE in a VERY short term in say Hotel or Cruiseline or Airline industry?

These are the days IF/WHEN a retail investor misses out on potential wild UP swings in the market, and say ADXS or whichever bio-tech you're heavily invested in, is sitting put, NOT necessarily moving up as much due to uncertainty/market conditions etc., then the retrail investor will miss out BIG in short run.. thoughts?

Thanks for chiming in.

P.S. I'm all for coming back to investing heavily in promising 'baby-bio investing' once the markets go back to normal..